Bioactivation of a Toxic Metabolite of Valproic Acid, (E)-2-Propyl-2,4-pentadienoic Acid, via Glucuronidation. LC/MS/MS Characterization of the GSH−Glucuronide Diconjugates-Reference-Cited by-同舟云学术

Bioactivation of a Toxic Metabolite of Valproic Acid, (E)-2-Propyl-2,4-pentadienoic Acid, via Glucuronidation. LC/MS/MS Characterization of the GSH−Glucuronide Diconjugates

Published:1996-01-01 Issue:2 Volume:9 Page:517-526
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Tang Wei¹,Abbott Frank S.¹

Affiliation:

1. Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx950120y

Reference42 articles.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A trend over time study of hepatic Farnesoid-X-activated receptor and its downstream targets modulation by valproic acid in mice;Toxicology Mechanisms and Methods;2024-06-18

2. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review;International Journal of Molecular Sciences;2023-12-27

3. Pharmacogenetics-Informed Pharmacometabolomics as an Innovative Approach to Assessing the Safety and Risk of Pharmacotherapy with Valproic Acid;Safety and Risk of Pharmacotherapy;2023-10-26

4. Therapeutic and Toxic Effects of Valproic Acid Metabolites;Metabolites;2023-01-16

5. Evidence of glucuronidation of the glycation product LW-1: tentative structure and implications for the long-term complications of diabetes;Glycoconjugate Journal;2018-01-05